Trial intelligence / Profile preview

Calcitonin stimulation: pentagastrin vs. calcium gluconate in chronic kidney disease

2011-002863-84Phase 2Completed

Sponsor
Medical University of Vienna
Start
Jan 2012
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 2 trial of pentagastrin and calcium gluconate (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Potency of calcitonin stimulation, Feasibility of stimulation tests and 1 more. Started Jan 2012; status: completed.

02

Drugs

pentagastrincalcium gluconate

Beyond the preview

Go deeper on 2011-002863-84.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002863-84.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call